
Merck to acquire London-based Verona Pharma for $10 billion
Merck announced on Wednesday that it will acquire the UK-based lung therapy company Verona Pharma for approximately $10 billion. This strategic move aims to bolster Merck's respiratory treatment offerings, as the U.S. pharmaceutical giant seeks to …